In the study, “92% of patients who received the combination therapy were alive at the five-year mark, compared with 71% of those who only used Keytruda… "I think this is a landmark advance in how we treat these very advanced, high-risk melanomas”
Kathleen Bachynski
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug. n.pr/4u3FHCZ
A study finds that an mRNA vaccine is highly effective at preventing recurrence of this dangerous skin cancer, when used in combination with Keytruda, an immunotherapy drug.
